| Literature DB >> 35989694 |
Peng Li1, Yongfa Liu1, Mingkun Gao1, Jiahuan Fu1, Yuming Guo1.
Abstract
The objective of this study was to determine the effects of dietary soy saponin (SS) on the antioxidant and immune functions of laying hens. Two hundred seventy 22-week-old Hy-line gray layers were randomly allocated into three treatment groups: a control group (Control) fed a basal diet with low soybean meal and groups supplemented with 50 and 500 mg/kg SS (50 SS and 500 SS). After ten weeks, eight chickens from each treatment group were anesthetized and sacrificed to collect tissue samples. In the 50 and 500 SS groups, results showed that the levels of superoxide dismutase (SOD) in serum and spleen were elevated, and the content of malondialdehyde (MDA) in serum decreased. The mRNA levels of genes such as NF-E2-related factor 2 (Nrf-2) in the ileum and Nrf-2 and SOD in the spleen were also upregulated. In addition, the skin irritation index of phytohemagglutinin (PHA), the number of serum white blood cells, and lymphocytes were elevated in the two groups. At the same time, the number of monocytes in the blood increased in the 50 SS group, and it was significantly higher in the 500 SS group. In addition, the mRNA levels of lysozyme (LYZ) and IFN-γ in the spleen were upregulated, similar to the mRNA levels of zinc finger protein A20 (A20) in the ileum. Furthermore, the mRNA levels of NF-κB and IL-6 in the ileum were downregulated. In conclusion, with supplementation of 50 and 500 mg/kg SS in low soybean meal diets, the antioxidant, and immune functions of laying hens were improved. More importantly, the target for SS to exert biological effects on laying hens may be in the intestine and spleen tissues. 2022, Japan Poultry Science Association.Entities:
Keywords: antioxidant; immune; layer; soy saponin
Year: 2022 PMID: 35989694 PMCID: PMC9346601 DOI: 10.2141/jpsa.0210073
Source DB: PubMed Journal: J Poult Sci ISSN: 1346-7395 Impact factor: 1.768
Test diet composition and nutrition level
| Ingredients | Nutritional parameters | Levels | |
|---|---|---|---|
| Corn (7.8% protein) | 67.550 | Metabolizable energy (ME, Mcal/kg) | 2.70 |
| Dephenolized cottonseed protein (50% protein) | 14.000 | Crude protein (%) | 16.53 |
| Limestone powder | 8.154 | Lysine (%) | 0.79 |
| corn gluten meal (51.3% protein) | 5.000 | Methionine (%) | 0.41 |
| Soybean meal (48% protein) | 2.000 | Calcium (%) | 3.63 |
| Ca (HCO3)2 | 1.860 | Total phosphorus (%) | 0.76 |
| NaCl | 0.350 | Available phosphorus (%) | 0.43 |
| Trace minerals | 0.300 | Methionine (%) | 0.68 |
| L-Lysine HCl (78%) | 0.250 | Threonine (%) | 0.58 |
| DL-Methionine | 0.120 | Tryptophan (%) | 0.16 |
| Choline chloride (50%) | 0.120 | ||
| Tryptophan | 0.020 | ||
| Multi-vitamins | 0.030 | ||
| Antioxidants | 0.030 | ||
| Phytase | 0.016 | ||
| Zeolite powder | 0.200 | ||
| Total | 100 |
Vitamin premix (provided per kilogram of feed) the following substances: vitamin A, 12,500 IU; vitamin D3, 2,500 IU; vitamin K3, 2.65 mg; vitamin B1, 2 mg; vitamin B2, 6 mg; vitamin B12, 0.025 mg; vitamin E, 30 IU; biotin, 0.0325 mg; folic acid, 1.25 mg; pantothenic acid, 12 mg; niacin, 50 mg.
Trace element premix (provided per kilogram of feed) the following substances: Cu, 8 mg; Zn, 75 mg; Fe, 80 mg; Mn, 100 mg; selenium, 0.15 mg; iodine, 0.35 mg.
List of primer sequences for genesa
| Gene name | Prime sequence (5′-3′) | Gene Bank | Product size, bp | |
|---|---|---|---|---|
|
| F | CCCAGGCTCCAGGAACCT | NM_205281 | 102 |
| R | CACGCTCGCTGTTATGTCTGA | |||
|
| F | ATGGAATAGGCTCTTGCTGTG | NM_001001194.1 | 119 |
| R | GCCAGATAGAATGGAGTTGGAG | |||
|
| F | CTCAGCCAGGTGTACTGTGCTT | NM_001001606.1 | 66 |
| R | CGTCATCCGCTTCAGTCTCA | |||
|
| F | CCCCTACCCTGTCCCACAA | NM_204267.1 | 67 |
| R | TGAGTACTGCGGAGGGTTCAT | |||
|
| F | CTTCCTGATGGCGTGAAGA | NM_205149.1 | 127 |
| R | GAGGATCCACCAGCTTCTGT | |||
|
| F | GACATCGTGCTAACAGCTTGGA | XM_003640919.2 | 180 |
| R | AGAAAAGAGGGTATCAGGCACAAC | |||
|
| F | TGGAGAAGGCTATGCAGCTT | NM_205134.1 | 117 |
| R | CATCCTGGACAGCAGTGAGA | |||
|
| F | GCGAGAACAGCATGGAGATG | AJ621249 | 82 |
| R | GTAGGTCTGAAAGGCGAACAG | |||
|
| F | GGCTTGCTAGGGGAAATGA | NM_205498.1 | 200 |
| R | AGCTGACTCTGACTAGGAAACTGT | |||
|
| F | ATCACCTCTTCTGCACCGAA | NM_205117.1 | 229 |
| R | GCTTTCTCCCGCTCTTTCTG | |||
|
| F | CCGGCTTGTCTGATGGAGAT | NM_205064.1 | 125 |
| R | TGCATCTTTTGGTCCACCGT | |||
|
| F | GACCAACCCGCAGTACATCA | NM_001277853.2 | 204 |
| R | GAGGTGCGGGCTTTCCTTTA | |||
|
| F | GAGAAATTGTGCGTGACATCA | NM_205518.1 | 152 |
| R | CCTGAACCTCTCATTGCCA |
Primers designed using Primer Express software (Sangon Biotech, Shanghai, China).
Abbreviations: LYZ, lysozyme; AVBD7, avian beta-defensin 7; Leap2, liver-expressed antimicrobial peptide 2; TNF-α, tumor necrosis factor α; IFN-γ, interferon γ; A20, zinc finger protein A20; NF-κB, nuclear transcription factor-kappa B; IL-6, interleukin 6; IL-8, interleukin 8; Nrf-2, NF-E2-related factor 2; SOD, superoxide dismutase; GPX-Px, glutathione peroxidase.
Fig. 1.The effects of soy saponin (SS) on the body weight of laying hens. Data represent the mean ± SEM (n=6) from our previous study (Li ).
Fig. 2.The effect of soy saponin (SS) on the gene mRNA levels of * represents a significant difference (P<0.05).
The effects of soy saponin (SS) on the levels of antioxidant-related enzymes and products in liver, ovaries, and shell gland (n=8)
| Item | Control | 50 ppm SS | 500 ppm SS |
| |
|---|---|---|---|---|---|
| Liver | CAT (U/mg protein) | 4.90±0.44 | 4.97±0.30 | 5.34±0.25 | 0.622 |
| MDA (nmol/mg protein) | 3.43±0.33 | 4.03±0.20 | 4.56±0.22 | 0.019 | |
| SOD (U/mg protein) | 25.63±2.18 | 28.60±3.03 | 29.22±1.90 | 0.544 | |
| GSH (U/mg protein) | 20.27±1.13 | 18.63±0.66 | 18.85±2.23 | 0.704 | |
|
| |||||
| Ovaries | CAT (U/mg protein) | 5.43±0.60 | 5.65±0.31 | 4.87±0.44 | 0.486 |
| MDA (nmol/mg protein) | 4.01±0.54 | 4.63±0.14 | 3.99±0.50 | 0.504 | |
| SOD (U/mg protein) | 42.76±5.54 | 39.28±1.99 | 37.73±2.06 | 0.608 | |
| GSH (U/mg protein) | 20.99±5.03 | 23.68±2.80 | 22.68±4.64 | 0.904 | |
|
| |||||
| Shell gland | CAT (U/mg protein) | 5.58±0.31 | 5.09±0.24 | 4.90±0.34 | 0.270 |
| MDA (nmol/mg protein) | 3.19±0.25 | 3.15±0.22 | 3.19±0.41 | 0.995 | |
| SOD (U/mg protein) | 58.01±2.95 | 62.76±2.59 | 63.36±0.80 | 0.224 | |
| GSH (U/mg protein) | 17.44±1.21 | 18.51±1.38 | 16.43±1.18 | 0.517 | |
Values with the same superscripts are not significantly different from each other at P<0.05.
Abbreviations: CAT, Catalase; MDA, Malondialdehyde; SOD, Superoxide dismutase; GSH, Glutathione peroxidase.
The effects of soy saponin (SS) on the levels of antioxidant-related enzymes and products in serum, spleen, and ileum (n=8)
| Item | Control | 50 ppm SS | 500 ppm SS |
| |
|---|---|---|---|---|---|
| Serum | CAT (U/mL) | 4.25±0.29 | 5.26±0.29 | 6.87±0.51 | <0.001 |
| MDA (nmol/mL) | 6.58±0.36 | 4.81±0.21 | 4.95±0.28 | <0.001 | |
| SOD (U/mL) | 201.09±1.67 | 210.15±2.79 | 203.18±2.69 | 0.040 | |
| GSH (U/mL) | 28.54±1.91 | 31.06±1.63 | 29.67±2.51 | 0.689 | |
|
| |||||
| Spleen | CAT (U/mg protein) | 17.96±1.46 | 24.12±1.40 | 19.35±1.27 | 0.012 |
| MDA (nmol/mg protein) | 1.86±0.09 | 1.29±0.09 | 1.78±0.16 | 0.005 | |
| SOD (U/mg protein) | 217.07±11.32 | 260.93±16.19 | 255.06±9.71 | 0.048 | |
| GSH (U/mg protein) | 19.40±1.74 | 24.05±2.01 | 21.23±1.92 | 0.238 | |
|
| |||||
| Ileum | CAT (U/mg protein) | 14.04±0.96 | 15.08±0.68 | 15.68±0.93 | 0.414 |
| MDA (nmol/mg protein) | 1.33±0.13 | 0.97±0.05 | 1.03±0.11 | 0.049 | |
| SOD (U/mg protein) | 219.91±7.12 | 264.60±20.23 | 261.23±28.26 | 0.251 | |
| GSH (U/mg protein) | 63.05±4.96 | 67.27±3.64 | 59.42±3.29 | 0.402 | |
Values with the same superscripts are not significantly different from each other at P<0.05.
Abbreviations: CAT, Catalase; MDA, Malondialdehyde; SOD, Superoxide dismutase; GSH, Glutathione per oxidase.
Fig. 3.The effect of soy saponin (SS) on the stimulus index of PHA. Data represent the mean ± SEM ( ** and *** represent a significant difference (P<0.01 and P<0.001), respectively.
The effects of soy saponin (SS) on the levels of blood cells at the end of the 5th week (n=8)
| Item | Control | 50 ppm SS | 500 ppm SS | |
|---|---|---|---|---|
| WBC | 72.34±0.86 | 74.40±1.06 | 77.75±1.02 | 0.003 |
| NETU% | 27.63±0.67 | 26.75±0.47 | 27.25±0.50 | 0.543 |
| NETU# | 19.95±0.34 | 19.89±0.38 | 21.18±0.30 | 0.024 |
| LYMPH% | 56.61±0.70 | 58.69±0.54 | 57.44±0.86 | 0.140 |
| LYMPH# | 40.95±0.63 | 43.68±0.86 | 44.65±0.69 | 0.005 |
| MONO% | 7.71±0.51 | 7.03±0.36 | 7.69±0.66 | 0.586 |
| MONO# | 5.61±0.41 | 5.21±0.27 | 6.00±0.55 | 0.442 |
| EO% | 6.53±0.53 | 6.19±0.32 | 6.11±0.52 | 0.803 |
| EO# | 4.73±0.41 | 4.61±0.26 | 4.78±0.44 | 0.953 |
| BASO% | 1.53±0.12 | 1.36±0.08 | 1.48±0.14 | 0.603 |
| BASO# | 1.10±0.09 | 1.01±0.05 | 1.15±0.11 | 0.556 |
Values with the same superscripts are not significantly different from each other at P<0.05.
Abbreviations: WBC, white blood cell; NETU%, ratio of neutrophils to WBC; NETU#, number of neutrophils; LYMPH%, ratio of lymphocytes to WBC; LYMPH#, number of lymphocytes; MONO%, ratio of monocytes to WBC; MONO#, number of monocytes; EO%, ratio of eosinophils to WBC; EO#, number of eosinophils; BASO%, ratio of basophils to WBC; BASO#, number of basophils.
The effects of soy saponin (SS) on the levels of blood cells at the end of the 10th week (n=8)
| Item | Control | 50 ppm SS | 500 ppm SS | |
|---|---|---|---|---|
| WBC | 71.00±1.02 | 76.74±1.56 | 76.98±1.49 | 0.009 |
| NETU% | 28.59±0.74 | 26.83±0.74 | 26.09±0.93 | 0.105 |
| NETU# | 20.31±0.68 | 20.54±0.53 | 20.01±0.45 | 0.803 |
| LYMPH% | 57.13±0.62 | 58.21±0.62 | 57.66±1.32 | 0.706 |
| LYMPH# | 40.55±0.70 | 44.69±1.12 | 44.33±1.03 | 0.011 |
| MONO% | 7.29±0.47 | 8.31±0.42 | 8.76±0.77 | 0.202 |
| MONO# | 5.16±0.32 | 6.39±0.37 | 6.80±0.68 | 0.065 |
| EO% | 5.71±0.57 | 5.35±0.75 | 6.01±0.88 | 0.821 |
| EO# | 4.05±0.41 | 4.11±0.60 | 4.70±0.75 | 0.705 |
| BASO% | 1.31±0.16 | 1.33±0.18 | 1.45±0.23 | 0.854 |
| BASO# | 0.93±0.11 | 1.01±0.14 | 1.14±0.19 | 0.619 |
Values with the same superscripts are not significantly different from each other at P<0.05.
Abbreviations: WBC, white blood cell; NETU%, the ratio of neutrophils to WBC; NETU#, the number of neutrophils; LYMPH%, the ratio of lymphocytes to WBC; LYMPH#, the number of lymphocytes; MONO%, the ratio of monocytes to WBC; MONO#, the number of monocytes; EO%, the ratio of eosinophils to WBC; EO#, the number of eosinophils; BASO%, the ratio of basophils to WBC; BASO#, the number of basophils.
Fig. 4.The effects of soy saponin (SS) on the mRNA levels of immune-related genes in the spleen (A) and ileum (B). The data of IFN-γ and TNF-α in spleen were from our previous study (Li ). Data represent the mean ± SEM (n=8). * represents a significant difference (P<0.05).